New York Physicians’ Perspectives and Knowledge of the State Medical Marijuana Program
Abstract Introduction: In 2014, New York (NY) became the 23rd state to legalize medical marijuana (MMJ). The purpose of this…
medical marijuana
Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey
Abstract Background: Regulatory barriers limit clinical trials of medical cannabis in the United States. Longitudinal cohort studies may be one…
A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes
Abstract Introduction: In Canada, the Access to Cannabis for Medical Purposes Regulations (ACMPR) has given nurse practitioners (NPs) the power…
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment
Abstract The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients…
Medical marijuana for the treatment of vismodegib-related muscle spasm
Keywords: basal cell carcinoma, medical marijuana, muscle cramps, vismodegib, BCC, basal cell carcinoma, CBD, cannabidiol, FDA, US Food and Drug…
Recent advances in understanding and managing cancer pain
Abstract Cancer pain remains a significant clinical problem worldwide. Causes of cancer pain are multifactorial and complex and are likely…
Leaner and greener analysis of cannabinoids
Abstract Electronic supplementary material: The online version of this article (doi:10.1007/s00216-017-0256-3) contains supplementary material, which is available to authorized users.…
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Abstract Currently, 25 states and Washington DC have enacted full medical marijuana (MMJ) programs while 18 states allow limited access…
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
Abstract A randomized, placebo-controlled crossover trial utilizing vaporized cannabis containing placebo and 6.7% and 2.9% delta-9-tetrahydrocannabinol (THC) was performed in…
Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids
Abstract The design of analgesic clinical trials invariably involves a comparison between placebo and active study medication. An assumption is…